Por: The New York Times Business July 22, 2023
In 2004, Gilead Sciences decided to stop pursuing a new H.I.V. drug. The was that it wasn’t sufficiently different from an existing treatment to warrant further development.In private, though, something else was at play. Gilead had to delay the new drug’s release to maximize profits, even though executives had reason to believe it might turn out to be safer for patients, according to a trove of internal documents made public in litigation... + full article
New York Post USA Life March 27, 2023
This Goop guru may not know it all. Earlier this month, wellness queen Gwyneth Paltrow doing rectal ozone therapy, but now, doctors are warning against it. The therapy, which uses medical-grade ozone gas administered through an ozone-generator device, can be inserted in your... + más
Is Gwyneth Paltrow’s Rectal Ozone Therapy Claim Backed By Any Evidence? | Forbes
Doctor slams Gwyneth Paltrow's health tips—'Don't put coffee in your butt' | Newsweek
New York Daily News USA Nation February 22, 2023
Facebook and Instagram’s parent company Meta has profited from more than 60 ads featuring the anti-LGBTQ slur “groomer” since December, according to a new report from Media Matters for America. The analysis comes just months after the progressive media watchdog nonprofit... + más
Facebook parent company Meta still cashing in on ads using anti-LGBTQ slur ‘groomers’ despite platform’s ban: report | New York Daily News
To defeat FTC lawsuit, Meta demands 100+ rivals share biggest trade secrets | Ars Technica
Forbes USA Life January 17, 2023
A California biopharmaceutical company has announced positive results from a clinical trial testing MDMA as a treatment for post-traumatic stress disorder, bolstering its efforts to gain federal approval for the therapeutic use of the psychedelic drug also known as ecstasy. A... + más
Op-Ed: Psychedelic treatments are here, but doctors aren't prepared | Los Angeles Times
MDMA use at start of pandemic rose almost 300 percent in New England town | Newsweek
Ars Technica USA Science January 05, 2023
Navigate Filter by topic Settings Front page layout Site theme - Jan 5, 2023 12:45 pm UTC MARK GARLICK/SCIENCE PHOTO LIBRARY Share this story Gene therapy has had a long and bumpy history. Although researchers have made some notable and Despite these issues, experts say there... + más
Opinion | The New York Times
First participant in test of custom gene editing therapy dies | The Boston Globe
The Advocate USA Health November 16, 2022
What is bright light therapy?For individuals with Alzheimer’s and other dementias, the circadian rhythm can be disrupted, resulting in sleep disorders and/or challenging behaviors. Bright light helps regulate the circadian rhythm, sometimes called the “body clock,” which... + más
Alzheimer's Q&A: Bright light therapy has multiple benefits | The Advocate
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
The New York Times USA Opinion October 11, 2022
When my new therapist asked why I was seeking therapy this past summer, I didn’t have a concrete answer.It wasn’t like the first time I’d gone to therapy, as a 21-year-old experiencing severe panic attacks every day. Then, a clear crisis had sent me out in search of... + más
Why would Mac Jones get a second opinion on his injury, and how common is that? | The Boston Globe
The left wants the Supreme Court to rule with public opinion only when it’s convenient | New York Post
The Advocate USA Health September 17, 2022
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
Alzheimer's Q&A: Talking it out helpful in first stages of disease | The Advocate
About iurex | Privacy Policy | Disclaimer |